Boundless Bio Inc. (BOLD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Boundless Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.50
+3.73% today
Market cap
$56M
Overall quality
57/100
Kronos AI 30-day
−0.7%
4 of 8 simulated paths end higher
Boundless Bio Inc. (BOLD) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $56M. It trades at $2.50, up 3.73% today. Its overall quality score is 57 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is −0.7% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $2.39 (−0.7%) |
| Likely range | −10.7% … +5.2% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 92 |
| Growth | 40 |
| Overall | 57 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.